Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| Aug 10 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 10,000 | $3.79 | $37.9K | +2.8% | Open the original filing on SEC.gov |
| Jul 10 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 10 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 28 | $29.68 | $831 | <0.1% | Open the original filing on SEC.gov |
| Jul 10 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 9,972 | $28.42 | $283.4K | -2.7% | Open the original filing on SEC.gov |
| Jul 10 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 10,000 | $3.79 | $37.9K | +2.8% | Open the original filing on SEC.gov |
| Jun 9 | RLAY | Relay Therapeutics, Inc. | AGRANT◆ | 32,947 | — | — | — | Open the original filing on SEC.gov |
| May 18 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 2,978 | $20.35 | $60.6K | -0.8% | Open the original filing on SEC.gov |
| May 18 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 12,022 | $19.96 | $240K | -3.2% | Open the original filing on SEC.gov |
| May 18 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 15,000 | $3.79 | $56.8K | +4.1% | Open the original filing on SEC.gov |
| Apr 20 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 15,000 | $23.61 | $354.1K | -4.0% | Open the original filing on SEC.gov |
| Apr 20 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 15,000 | $3.79 | $56.8K | +4.1% | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 7,080 | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 7,454 | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,226 | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 7,080 | $5.45 | $38.6K | +2.0% | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 7,454 | $3.79 | $28.2K | +2.1% | Open the original filing on SEC.gov |
| Apr 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,226 | $4.44 | $36.5K | +2.4% | Open the original filing on SEC.gov |